Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19

@article{Juno2020ImmunogenicPO,
  title={Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19},
  author={J. Juno and H. Tan and W. S. Lee and A. Reynaldi and H. Kelly and K. Wragg and R. Esterbauer and H. Kent and C. Batten and F. Mordant and N. Gherardin and P. Pymm and M. Dietrich and N. Scott and W. Tham and D. Godfrey and K. Subbarao and M. Davenport and S. Kent and A. Wheatley},
  journal={medRxiv},
  year={2020}
}
The rapid global spread of SARS-CoV-2 and resultant mortality and social disruption have highlighted the need to better understand coronavirus immunity to expedite vaccine development efforts. Multiple candidate vaccines, designed to elicit protective neutralising antibodies targeting the viral spike glycoprotein, are rapidly advancing to clinical trial. However, the immunogenic properties of the spike protein in humans are unresolved. To address this, we undertook an in-depth characterisation… Expand
Antibody response to SARS-CoV-2 infection in humans: a systematic review
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 RBD variants with a novel competitive multiplex assay
Cellular immune response to SARS-CoV-2 infection in humans: a systematic review
...
1
2
...

References

SHOWING 1-10 OF 44 REFERENCES
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors
A serological assay to detect SARS-CoV-2 seroconversion in humans
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.
  • J. Sui, Wenhui Li, +11 authors W. Marasco
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2004
...
1
2
3
4
5
...